Cargando…
Argon: Neuroprotection in in vitro models of cerebral ischemia and traumatic brain injury
INTRODUCTION: Recently, it has been shown in several experimental settings that the noble gases xenon and helium have neuroprotective properties. In this study we tested the hypothesis that the noble gas argon has a neuroprotective potential as well. Since traumatic brain injury and stroke are wides...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2811924/ https://www.ncbi.nlm.nih.gov/pubmed/20017934 http://dx.doi.org/10.1186/cc8214 |
_version_ | 1782176812507332608 |
---|---|
author | Loetscher, Philip D Rossaint, Jan Rossaint, Rolf Weis, Joachim Fries, Michael Fahlenkamp, Astrid Ryang, Yu-Mi Grottke, Oliver Coburn, Mark |
author_facet | Loetscher, Philip D Rossaint, Jan Rossaint, Rolf Weis, Joachim Fries, Michael Fahlenkamp, Astrid Ryang, Yu-Mi Grottke, Oliver Coburn, Mark |
author_sort | Loetscher, Philip D |
collection | PubMed |
description | INTRODUCTION: Recently, it has been shown in several experimental settings that the noble gases xenon and helium have neuroprotective properties. In this study we tested the hypothesis that the noble gas argon has a neuroprotective potential as well. Since traumatic brain injury and stroke are widespread and generate an enormous economic and social burden, we investigated the possible neuroprotective effect in in vitro models of traumatic brain injury and cerebral ischemia. METHODS: Organotypic hippocampal slice cultures from mice pups were subjected to either oxygen-glucose deprivation or to a focal mechanical trauma and subsequently treated with three different concentrations (25, 50 and 74%) of argon immediately after trauma or with a two-or-three-hour delay. After 72 hours of incubation tissue injury assessment was performed using propidium iodide, a staining agent that becomes fluorescent when it diffuses into damaged cells via disintegrated cell membranes. RESULTS: We could show argon's neuroprotective effects at different concentrations when applied directly after oxygen-glucose deprivation or trauma. Even three hours after application, argon was still neuroprotective. CONCLUSIONS: Argon showed a neuroprotective effect in both in vitro models of oxygen-glucose deprivation and traumatic brain injury. Our promising results justify further in vivo animal research. |
format | Text |
id | pubmed-2811924 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-28119242010-01-28 Argon: Neuroprotection in in vitro models of cerebral ischemia and traumatic brain injury Loetscher, Philip D Rossaint, Jan Rossaint, Rolf Weis, Joachim Fries, Michael Fahlenkamp, Astrid Ryang, Yu-Mi Grottke, Oliver Coburn, Mark Crit Care Research INTRODUCTION: Recently, it has been shown in several experimental settings that the noble gases xenon and helium have neuroprotective properties. In this study we tested the hypothesis that the noble gas argon has a neuroprotective potential as well. Since traumatic brain injury and stroke are widespread and generate an enormous economic and social burden, we investigated the possible neuroprotective effect in in vitro models of traumatic brain injury and cerebral ischemia. METHODS: Organotypic hippocampal slice cultures from mice pups were subjected to either oxygen-glucose deprivation or to a focal mechanical trauma and subsequently treated with three different concentrations (25, 50 and 74%) of argon immediately after trauma or with a two-or-three-hour delay. After 72 hours of incubation tissue injury assessment was performed using propidium iodide, a staining agent that becomes fluorescent when it diffuses into damaged cells via disintegrated cell membranes. RESULTS: We could show argon's neuroprotective effects at different concentrations when applied directly after oxygen-glucose deprivation or trauma. Even three hours after application, argon was still neuroprotective. CONCLUSIONS: Argon showed a neuroprotective effect in both in vitro models of oxygen-glucose deprivation and traumatic brain injury. Our promising results justify further in vivo animal research. BioMed Central 2009 2009-12-17 /pmc/articles/PMC2811924/ /pubmed/20017934 http://dx.doi.org/10.1186/cc8214 Text en Copyright ©2009 Loetscher et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Loetscher, Philip D Rossaint, Jan Rossaint, Rolf Weis, Joachim Fries, Michael Fahlenkamp, Astrid Ryang, Yu-Mi Grottke, Oliver Coburn, Mark Argon: Neuroprotection in in vitro models of cerebral ischemia and traumatic brain injury |
title | Argon: Neuroprotection in in vitro models of cerebral ischemia and traumatic brain injury |
title_full | Argon: Neuroprotection in in vitro models of cerebral ischemia and traumatic brain injury |
title_fullStr | Argon: Neuroprotection in in vitro models of cerebral ischemia and traumatic brain injury |
title_full_unstemmed | Argon: Neuroprotection in in vitro models of cerebral ischemia and traumatic brain injury |
title_short | Argon: Neuroprotection in in vitro models of cerebral ischemia and traumatic brain injury |
title_sort | argon: neuroprotection in in vitro models of cerebral ischemia and traumatic brain injury |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2811924/ https://www.ncbi.nlm.nih.gov/pubmed/20017934 http://dx.doi.org/10.1186/cc8214 |
work_keys_str_mv | AT loetscherphilipd argonneuroprotectionininvitromodelsofcerebralischemiaandtraumaticbraininjury AT rossaintjan argonneuroprotectionininvitromodelsofcerebralischemiaandtraumaticbraininjury AT rossaintrolf argonneuroprotectionininvitromodelsofcerebralischemiaandtraumaticbraininjury AT weisjoachim argonneuroprotectionininvitromodelsofcerebralischemiaandtraumaticbraininjury AT friesmichael argonneuroprotectionininvitromodelsofcerebralischemiaandtraumaticbraininjury AT fahlenkampastrid argonneuroprotectionininvitromodelsofcerebralischemiaandtraumaticbraininjury AT ryangyumi argonneuroprotectionininvitromodelsofcerebralischemiaandtraumaticbraininjury AT grottkeoliver argonneuroprotectionininvitromodelsofcerebralischemiaandtraumaticbraininjury AT coburnmark argonneuroprotectionininvitromodelsofcerebralischemiaandtraumaticbraininjury |